Skip to content

Screening for Postpartum Depression and Associated Risk Factors Among Women Who Deliver in Four Hospital in France During the COVID-19 Epidemic

Screening for Postpartum Depression and Associated Risk Factors Among Women Who Deliver in Four Hospital in France During the COVID-19 Epidemic

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04487171
Acronym
COVIE-19/20
Enrollment
38
Registered
2020-07-27
Start date
2020-05-25
Completion date
2024-01-20
Last updated
2026-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid19, Postpartum Depression, Prevalence, Social Distance

Keywords

Postpartum Depression, Covid19, Prevalence, Social Distance

Brief summary

Postpartum depression (PPD) represent around 15% of birth in developed countries. The context of the COVID-19 epidemy represents a possible source of additional emotional distress. The objective of this study is to determine the screening prevalence and risk factors of postpartum depression, among women who deliver in fourth hospital in the North of France in the context of the COVID epidemy.

Interventions

OTHERQuestionnaire

The mothers were administrated three questionnaires, (i) the Edinburgh Postnatal Depression Scale (EPDS), (ii) the State-Trait Anxiety Inventory (STAI-YA), and (iii) the Mother-to-Infant Bonding Scale (MIBS) in two stages, on days 2-3 after delivery and during a phone call between days 25-35.

Sponsors

Centre Hospitalier Universitaire, Amiens
Lead SponsorOTHER
Centre Hospitalier de Beauvais
CollaboratorOTHER
Central Hospital Saint Quentin
CollaboratorOTHER_GOV
Centre Hospitalier Intercommunal de Compiègne-Noyon
CollaboratorOTHER_GOV

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Single baby delivery * alive new born child without admission in neonatal intensive care unit * French-speaking mother * mother older than 18 years old

Exclusion criteria

* Patients who refuses the inclusion

Design outcomes

Primary

MeasureTime frameDescription
Variation of prevalence of clinically-significant post-partum depressive symptomsup to 35 days after deliveryVariation of prevalence of clinically-significant post-partum depressive symptoms

Countries

France

Contacts

PRINCIPAL_INVESTIGATORArthur FOULON, MD

CHU Amiens

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 12, 2026